CMT2 Recombinant Rabbit Monoclonal Antibody [JE06-60]
cat.: HA722690
| Product Type: | Recombinant Rabbit monoclonal IgG, primary antibodies |
|---|---|
| Species reactivity: | Human |
| Applications: | WB |
| Clonality: | Monoclonal |
| Clone number: | JE06-60 |
| Form: | Liquid |
| Storage condition: | Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term. |
| Storage buffer: | 1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide. |
| Concentration: | 1ug/ul |
| Purification: | Protein A affinity purified. |
| Molecular weight: | Predicted band size: 31 kDa |
| Isotype: | IgG |
| Immunogen: | Synthetic peptide within human CMT2 aa 225-274 / 274. |
| Positive control: | HeLa cell lysate, HepG2 cell lysate, A431 cell lysate, A549 cell lysate, K-562 cell lysate. |
| Subcellular location: | Nucleus, Cytoplasm, cytoskeleton, spindle. |
| Recommended Dilutions:
WB |
1:1,000 |
| Uniprot #: | SwissProt: Q15013 Human |
| Alternative names: | Caught by MAD2 protein CMT2 dJ261G23.1 KIAA0110 MAD2L1 binding protein MAD2L1 binding protein isoform 2 MAD2L1-binding protein Mad2l1bp MD2BP_HUMAN MGC11282 OTTHUMP00000016496 RP1 261G23.6 |
Images
|
Fig1:
Western blot analysis of CMT2 on different lysates with Rabbit anti-CMT2 antibody (HA722690) at 1/1,000 dilution. Lane 1: HeLa cell lysate Lane 2: HepG2 cell lysate Lane 3: A431 cell lysate Lane 4: A549 cell lysate Lane 5: K-562 cell lysate Lysates/proteins at 20 µg/Lane. Predicted band size: 31 kDa Observed band size: 35 kDa Exposure time: 3 minutes; ECL: K1801; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA722690) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. |
Note: All products are “FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE”.